Pericyte PDGFR‐β deficiency contributes to Aβ pathology through impaired glymphatic transport and altered AQP‐4 localization
Alzheimer's & Dementia · 2026-11 · 22 (11)
DOI: 10.1002/alz.71991 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 17.11.2026. Verfasst von Hai‐Chao Chen und 9 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Gansu Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
INTRODUCTION Pericyte platelet‐derived growth factor receptor‐β (PDGFR‐β) signaling maintains neurovascular integrity, but its role in glymphatic function is unknown. We investigated whether pericyte PDGFR‐β deficiency is associated with glymphatic dysfunction and altered aquaporin‐4 (AQP‐4) localization in Alzheimer's disease (AD). METHODS Glymphatic trafficking was assessed by fluorescent cerebrospinal fluid (CSF) tracer injection. Meningeal lymphatic drainage was blocked by deep cervical lymph node (dcLN) ligation. Pericyte coverage, AQP‐4 expression/localization, and basement membrane components were analyzed by immunofluorescence and western blot. Pericyte‐conditioned medium was used to examine the effects of pericyte‐derived factors on astrocytic AQP‐4. The AQP‐4 facilitator TGN‐073 was administered to assess functional rescue. Blood–brain barrier integrity, microvascular density, and cerebral blood flow were also evaluated. RESULTS DcLN ligation impaired amyloid beta clearance and spatial memory. Both APP/PS1 and Pdgfr‐β+/− mice exhibited pericyte loss and glymphatic dysfunction, with Pdgfr‐β+/− mice additionally showing reduced perivascular AQP‐4 expression, accompanied by decreased laminin‐α2/β1. In vitro, pericyte‐derived factors promoted AQP‐4 expression. TGN‐073 partially improved small‐molecule CSF tracer distribution in Pdgfr‐β+/− mice. Pdgfr‐β+/−/APP/PS1 mice displayed exacerbated AD‐like pathology. DISCUSSION PDGFR‐β deficiency compromises basement membrane integrity and AQP‐4 localization, impairing glymphatic transport and accelerating AD pathogenesis. The PDGFR‐β pathway may represent a novel therapeutic target for enhancing waste clearance.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Gansu Province
- China Postdoctoral Science Foundation
Zitieren
APA
Chen, H., Gao, F., He, C., Yao, M., Shi, Y., Zhou, S., Zhang, X., Li, C., Gao, L., & Jing, Y. (2026). Pericyte PDGFR‐β deficiency contributes to Aβ pathology through impaired glymphatic transport and altered AQP‐4 localization. Alzheimer's & Dementia, 22(11). https://doi.org/10.1002/alz.71991
Vancouver
Chen H, Gao F, He C, Yao M, Shi Y, Zhou S, et al. Pericyte PDGFR‐β deficiency contributes to Aβ pathology through impaired glymphatic transport and altered AQP‐4 localization. Alzheimer's & Dementia. 2026;22(11). doi:10.1002/alz.71991
BibTeX
@article{Chen2026,
author = {Chen, Hai‐Chao and Gao, Fu‐Lin and He, Can and Yao, Min‐Hua and Shi, Ya‐Xuan and Zhou, Si‐Wei and Zhang, Xiao‐Yu and Li, Chuan‐Xiong and Gao, Li‐Ping and Jing, Yu‐Hong},
title = {Pericyte PDGFR‐β deficiency contributes to Aβ pathology through impaired glymphatic transport and altered AQP‐4 localization},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {11},
doi = {10.1002/alz.71991}
}
EUVIMED